ArticleJournal of clinical laboratory analysis2021

Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.

Anna Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.